Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
HSF1
-mediated heat shock response is activated in most tumors and plays important roles in regulating tumor homeostasis. However, the signals underlying
HSF1
activation is still not completely understood. In this paper, we find that glucose, the dominant tumor energy supplement, participates in regulating
HSF1
's activation in
HCC
cell lines. The immunoblotting results indicate that the phosphorylation of
HSF1
/S326, a hallmark of
HSF1
activation, varies between the
HCC
cell lines (e.g., SMMC7721, HapG2, plc/prf5, and Chang-liver). Glucose, but not 2D-glucose, can induce the phosphorylation of
HSF1
at S326 and upregulate the expression of
HSF1
's downstream alpha B-crystallin and Hsp70 as well as the none-heat shock proteins CSK2 and RBM23 in two tested hepatocellular carcinoma cell lines (prl/prf5 and SMMC7721). Rapamycin, an inhibitor of mTOR, can suppress the glucose-induced phosphorylation of
HSF1
/S326 and the expression of alpha B-crystallin. Knockdown of
HSF1
with shRNA enhances the glucose-depletion-mediated inhibition of plc/prf5 cell proliferation. Our data reveal that
HSF1
can be activated by glucose-mTOR pathway, providing an alternative pathway for targeting
HSF1
in tumor therapy.
...
PMID:Glucose regulates heat shock factor 1 transcription activity via mTOR pathway in HCC cell lines. 2601 Jul 66